Dr. Leal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd NE
4th floor, Room C4004
Atlanta, GA 30322Phone+1 404-251-5544Fax+1 404-778-5520- Is this information wrong?
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2007 - 2009
- University of Illinois College of Medicine at ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2006 - 2007
- Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2003 - 2006
- Federal University of Ceara Faculty of MedicineClass of 2001
Certifications & Licensure
- GA State Medical License 2021 - 2025
- WI State Medical License 2007 - 2023
- IL State Medical License 2003 - 2017
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Start of enrollment: 2011 Jun 20
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b...Michael F Bassetti, Brett A Morris, Nan Sethakorn, Joshua M Lang, Jennifer L Schehr, Shuang George Zhao, Zachary S Morris, Darya Buehler, Jens C Eickhoff, Paul M Harar...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
- DNA topoisomerase II inhibition potentiates osimertinib's therapeutic efficacy in EGFR-mutant non-small cell lung cancer models.Chen, Z., Vallega, K., Wang, D., Quan, Z., Fan, S., Wang, Q., Sun, S., Leal, T., Ramalingam, S.> ;The Journal of Clinical Investigation. 2024 Mar 7
- Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Cha...Ticiana A Leal, Anandaroop Dasgupta, Dominick Latremouille-Viau, Carmine Rossi, Pragya Rai, Fabrice Barlesi, Stephen V Liu> ;JCO Global Oncology. 2024 Mar 1
- Join now to see all
Press Mentions
- Chemo Regimen Boosts Gefitinib in EGFR-Mutant Lung Cancer, but at What Cost?June 5th, 2019
- Carbone Experts Present Latest Research at World's Largest Cancer MeetingMay 31st, 2019
- Addition of Bevacizumab to Carboplatin/Pemetrexed in Nonsquamous NSCLCMay 29th, 2019
- Join now to see all
Hospital Affiliations
- Emory University HospitalAtlanta, Georgia
- University HospitalMadison, Wisconsin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: